Increase of TNFα-stimulated osteoarthritic chondrocytes apoptosis and decrease of matrix metalloproteinases 9 by NF-κB inhibition

Biomedical and Environmental Sciences

Volumn 26, Issue 4, 2013, Pages 277-283

  Wang, Yan ^a   Li, De Ling ^a,b   Zhang, Xin Bo ^c   Duan, Yuan Hui ^b   Wu, Zhi Hong ^b   Hao, Dong Sheng ^b   Chen, Bao Sheng ^c   Qiu, Gui Xing ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Chondrocytes; Gelatinase; NF B; Tumor necrosis factor

Indexed keywords

CAFFEIC ACID DERIVATIVE; CAFFEIC ACID PHENETHYL ESTER; CALCIUM; DRUG DERIVATIVE; GELATINASE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PHENETHYL ALCOHOL; TUMOR NECROSIS FACTOR ALPHA;

AGED; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; NF-ΚB; OSTEOARTHRITIS; PHYSIOLOGY; SECRETION (PROCESS); TUMOR NECROSIS FACTOR Α;

APOPTOSIS; CHONDROCYTES; GELATINASE; NF-ΚB; TUMOR NECROSIS FACTOR Α;

AGED; APOPTOSIS; CAFFEIC ACIDS; CALCIUM; CELLS, CULTURED; CHONDROCYTES; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NF-KAPPA B; OSTEOARTHRITIS; PHENYLETHYL ALCOHOL; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 84880238066     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2013.04.006     Document Type: Article

References (32)

1. Felson DT. Comparing the prevalence of rheumatic disease in China with the rest of the world. Arthritis Research & Therapy, 2008;10, 1-2.
2. Hussein MR, Fathi NA, El-Din AM, et al. Alterations of the CD4 (+), CD8 (+) T cell subsets, interleukins-lbeta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res, 2008;14, 321-8.
3. Hulejova H, Baresova V, Klezl Z, et al. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine, 2007;38, 151-6.
4. Urech DM. Anti-inflammatory and cartilage-protecting efffects of an intra-articularly injected anti-TNFa single-chain Fv antibody (ESBA105) designed for local therapeutic use. Ann Rheum Dis, 2010;69, 443-9.
5. Murphy G, Knauper V, Atkinson S, et al. Matrix metalloproteinases in arthritic disease. Arthritis Res, 2002;4 Suppl 3, S39-49.
6. Kevorkian L. Expression profiling of metalloproteinases and their inhibitors in cartilage Arthritis & Rheumatism, 2004;50, 131-41.
7. Jouglin M, Robert C, Valette JP, et al. Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Vet Res, 2000;31, 507-15.
8. Chu SC, Yang SF, Lue KH, et al. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee. Connect Tissue Res, 2004;45, 142-50.
9. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev, 2004;18, 2195-224.
10. lO. Chen LX, Lin L, Wang HJ, et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage, 2008;16, 174-84.
11. ll. Yao Z, Xing L, Boyce BF. NF-kappaB plOO limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest, 2009;119, 3024-34.
12. Li D, Wu Z, Duan Y, et al. TNFalpha-mediated apoptosis in human osteoarthrjtic chondrocytes sensitized by PI3K-NF-kappaB inhibitor, not mTOR inhibitor. Rheumatol Int, 2011 Apr. 9, DOI 10.1007/s00296-011-1929-4.
13. Yoon HS, Kim HA, Song YW. Inhibition of NF-kappaB renders human juvenile costal chondrocyte cell lines sensitive to TNF-alpha-mediated cell death. Rheumatol Int, 2006;26, 201-8.
14. Lee CW, Lin CC, Lin WN, et al. TNF-alpha induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-kappaB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol, 2007;292, L799-812.
15. l5. Duxbury MS, Whang EE. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness. Biochem Biophys Res Commun, 2007;354, 190-6.
16. Makowski GS, Ramsby ML. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates. Clin Chim Acta, 2005;358, 182-91.
17. Relic B B-AM, Ribbens C, Franchimont N, et al. TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Lab Invest, 2002;82, 1661-72.
18. Kim KS, Choi HM, Lee YA, et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int, 2011;31(4), 543-7.
19. Hsieh YS, Yang SF, Chu SC, et al. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement. Arthroscopy, 2004;20, 482-8.
20. Xue M, March L, Sambrook PN, et al. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. Arthritis Rheum, 2007;56, 2864-74.
21. Soder S, Roach HI, Oehler S, et al. MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin Exp Rheumatol, 2006;24, 302-4.
22. Duerr S, Stremme S, Soeder S, et al. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and is increased in osteoarthritic cartilage. Clin Exp Rheumatol, 2004;22, 603-8.
23. Clements DN, Fitzpatrick N, Carter SD, et al. Cartilage gene expression correlates with radiographic severity of canine elbow osteoarthritis. Vet J, 2009;179, 211-8.
24. Davidson RK, Waters JG, Kevorkian L, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther, 2006;8, R124.
25. Makowski GS, Ramsby ML. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection. Clin Chim Acta, 2003;329, 77-81.
26. Francoz D, Desrochers A, Simard N, et al. Relative expression of matrix metalloproteinase-2 and -9 in synovial fluid from healthy calves and calves with experimentally induced septic arthritis. Am J Vet Res, 2008;69, 1022-8.
27. McQuibban GA, Gong JH, Tarn EM, et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science, 2000;289, 1202-6.
28. McQuibban GA, Gong JH, Wong JP, et al. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood, 2002;100, 1160-7.
29. Lianxu C, Hongti J, Changlong Y. NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-lbeta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage, 2006;14, 367-76.
30. Cheng T, Petraglia AL, Li Z, et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med, 2006;12, 1278-85.
31. Fietz S, Einspanier R, Hoppner S, et al. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays. Equine Vet J, 2008;40, 266-71.
32. Xu J, Wu HF, Ang ES, et al. NF-kappaB modulators in osteolytic bone diseases. Cytokine Growth Factor Rev, 2009;20, 7-17.